Fritextsökning
Innehållstyper
-
Ny specialtidning och nytt event i Köpenhamn – Det händer hos Life Science Sweden 2024
Det nya året bjuder på nyheter för Life Science Swedens läsare.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Lucka 9 - vem där?
Kontakt med innovativa jättebolag finns bland julönskningarna i dagens lucka.
-
Klockringning när life science-kongressen i Lund drog igång
Innovation, finansiering och tillväxt är på agendan när eventet The future of Swedish and Danish Life Science nu dragit igång i Medicon Village i Lund. Och det ...
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
LEO Pharma - International Clinical Trial Manager
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Anna Törner: ”Orphan designation läkemedelsutvecklingens ’petite robe noire’”
Det är så lätt att klamra sig fast vid olika regulatoriska incitament, som orphan designation, utan att egentligen veta vad de innebär och på vilket sätt de kan...
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Sales Representative, Applied Biosystems
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
Reidar Rasmussen, Labmodul
Why are you going to Scanlab and Biotech Forum?
-
Optimism på Xspray efter uppgörelse i patenttvist
En uppgörelse uppges ha nåtts i patenttvisten mellan svenska forskningsbolaget Xspray Pharma och läkemedelsjätten Bristol Myers Squibb (BMS) om cancerkandidaten Dasynoc.
-
Studie: Fettsyror förbättrade synen hos för tidigt födda barn
En kombination av två fettsyror har en positiv effekt på synen hos för tidigt födda barn enligt en ny studie från Göteborgs universitet.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Peptider kan bli framtidens läkemedel
Tyska forskare rapporterar ett genombrott i arbetet med att göra små proteiner tillgängliga som läkemedel i pillerform.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Galderma bygger nytt
Planerar ny tillverkningsanläggning i Uppsala och visar upp lovande resultat från studie med ready to use-lösning av botulinumtoxin.